Nuclera Announces Appointment of Colin Barnes and Kristine Friscino to its Executive Leadership Team
- Date 6 Jun 2022
Nuclera, a biotechnology company accelerating protein expression workflows, has announced the appointment of two new members of their team: Colin Barnes, as VP of Intellectual Property and Kristine Friscino, as AVP of Marketing.
“We are so excited to have both Colin and Kristine on board. In this challenging labor market, we’ve been extremely fortunate to source top-tier, experienced industry professionals to build out our leadership team” said Dr. Michael Chen, CEO and cofounder of Nuclera. “These hires fill the last two open positions on our executive leadership team and we’re excited to now fully focus on the commercial launch of our eProtein desktop bioprinter in 2023.”
You might also be interested in these articles
Steaming up Success: ARU student’s path from café to creativity
We recently did a Q&A session with Anglia Ruskin student Soorya Jith, who started his journey as a Barista at the Lakeside Café within the Bradfield Centre on Cambridge Science Park. He has now transitioned to Krank, also located on the Park, as a Junior Graphic Designer.
Sun 21 Apr 2024
Cambridge Science Park
Cambridge Future Tech Expands its Board with the Appointment of Michael Beer and Jem Davies as Non-Executive Directors
Leading DeepTech Venture-Builder Further Strengthens its Unique Position to Cultivate Innovative Technologies with the Addition of Seasoned Industry Professionals
Sun 14 Apr 2024
Cambridge Future Tech
Xampla welcomes former P&G chemist to team as scale-up accelerates
accelerates CREATOR of plastic-free, natural materials, Xampla, continues to scale-up the commercialisation of its biodegradable Morro materials with new industry hire.
Fri 1 Mar 2024
Xampla Ltd
